Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999;5(1):73-9.
doi: 10.1053/paor.1999.0073.

Human herpesvirus 8 in hematologic diseases

Affiliations
Free article
Review

Human herpesvirus 8 in hematologic diseases

G Mikala et al. Pathol Oncol Res. 1999.
Free article

Abstract

Human herpesvirus type 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV) is a new member of the g-herpesvirus family. It is an unusual herpesvirus in that it carries a large number of genes that encode oncoproteins or cell signaling proteins. In addition to being the causative agent of both HIV-associated and non-HIV-associated Kaposi's sarcoma this DNA tumor virus has been implicated in the pathogenesis of several diseases. These include multiple myeloma (MM), Waldenstöm's macroglobulinemia (WM), multicentric Castleman's disease (MCD), body cavity-based lymphoma (BCBL), and various other conditions such as sarcoidosis and pemphigus. While the causative role of the viral infection is fairly certain in the development of BCBL and multicentric Castleman's disease, HHV-8 may act through a different mechanism to induce plasma cell malignancies. It has been suggested though the finding is still controversial - that infection of bone marrow stromal dendritic cells by HHV-8 might be a key factor in the etiology and pathogenesis of monoclonal gammopathies. The aim of this review is to provide a short introduction into the tumorigenic potential of HHV-8 as well as to detail the available data and possible mechanisms on the involvement of this virus in different hematologic diseases.

PubMed Disclaimer

References

    1. Lancet. 1996 Sep 28;348(9031):858-61 - PubMed
    1. Blood. 1998 Jun 1;91(11):4393-4 - PubMed
    1. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14862-7 - PubMed
    1. Science. 1997 Jun 20;276(5320):1788-9 - PubMed
    1. Blood. 1998 Apr 1;91(7):2475-81 - PubMed

Publication types

MeSH terms

LinkOut - more resources